🇺🇸 FDA
Patent

US 10125361

Compositions and methods of nucleic acid-targeting nucleic acids

granted A61KA61K38/465A61K47/549

Quick answer

US patent 10125361 (Compositions and methods of nucleic acid-targeting nucleic acids) held by Caribou Biosciences, Inc. expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Caribou Biosciences, Inc.
Grant date
Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/465, A61K47/549, A61K47/6455, A61P